Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Abliva on the public offer from Pharming
Mandate

Vinge advises Abliva on the public offer from Pharming

December 16, 2024 Capital Markets and Public M&A

Pharming Technologies B.V., a wholly owned subsidiary of Pharming Group N.V., has announced a public offer to the shareholders of Abliva AB (publ). The total value of the offer is approximately SEK 725 million.

The Vinge team includes Christian Lindhé, Erik Sjöman, Martin Madsen Svanberg and Agaton Lindgren.

Related

Vinge advises EQT AB on its combination with Coller Capital

 Vinge advises EQT AB on its acquisition Coller Capital, a global secondaries firm with nearly USD 50 billion in total assets under management across institutional, private wealth and insurance-related capital.
January 22, 2026

Vinge advises Nordic Re-Finance AB on a Swedish railway financing

Vinge has acted as Swedish legal counsel to Nordic Re-Finance AB, a leading lessor of locomotives for rail freight traffic in Scandinavia, in connection with the execution of a EUR 250m debt package fully underwritten by Natixis CIB.
January 21, 2026

Vinge has advised Eleda in connection with Eleda Norge AS’s acquisition of Nettpartner Bane AS

 Vinge, together with Advokatfirmaet Thommessen, has advised Eleda in connection with Eleda Norge AS’s acquisition of Nettpartner Bane AS from Å Energi owned Nettpartner AS.
January 19, 2026